Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Comparison of Standard vs. Accelerated Corneal Crosslinking for Treatment of Progressive Keratoconus or Ectasia

NCT03922542 is registered in ClinicalTrials.gov with Price Vision Group as lead sponsor.

NCT NCT03922542
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03922542 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Comparison of Standard vs. Accelerated Corneal Crosslinking for Treatment of Progressive Keratoconus or Ectasia
Lead sponsor
Price Vision Group
Phase
Phase 2/3
Overall status
Completed
Start date
April 16, 2019
Completion date
June 30, 2026
Enrollment
508 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ectasia corneal, keratoconus